AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)
CUSIP: 03152W109
Q4 2016 13F Holders as of 31 Dec 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 312,579,912
- Total 13F shares
- 156,858,667
- Share change
- +8,003,285
- Total reported value
- $779,548,508
- Put/Call ratio
- 25%
- Price per share
- $4.97
- Number of holders
- 130
- Value change
- +$23,503,784
- Number of buys
- 77
- Number of sells
- 59
Quarterly Holders Quick Answers
What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03152W109:
Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
6.8%
|
21,320,863
|
$157,774,000 | — | 30 Sep 2016 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
4.5%
|
14,116,644
|
$104,463,000 | — | 30 Sep 2016 | |
| Redmile Group, LLC |
13F
|
Company |
4.1%
|
12,751,536
|
$94,361,000 | — | 30 Sep 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.5%
|
7,956,543
|
$58,879,000 | — | 30 Sep 2016 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.5%
|
7,906,476
|
$58,508,000 | — | 30 Sep 2016 | |
| JANUS HENDERSON INVESTORS US LLC |
13F
|
Company |
2.5%
|
7,708,080
|
$57,040,000 | — | 30 Sep 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
2.1%
|
6,634,693
|
$49,097,000 | — | 30 Sep 2016 | |
| Palo Alto Investors LP |
13F
|
Company |
1.8%
|
5,685,388
|
$42,072,000 | — | 30 Sep 2016 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
5,093,598
|
$37,694,000 | — | 30 Sep 2016 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.4%
|
4,339,335
|
$32,111,000 | — | 30 Sep 2016 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
1.3%
|
4,194,452
|
$31,039,000 | — | 30 Sep 2016 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.3%
|
4,020,283
|
$29,750,000 | — | 30 Sep 2016 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1.2%
|
3,689,857
|
$27,305,000 | — | 30 Sep 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
1.1%
|
3,444,510
|
$25,489,000 | — | 30 Sep 2016 | |
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
0.83%
|
2,600,014
|
$19,240,000 | — | 30 Sep 2016 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.74%
|
2,299,071
|
$17,013,000 | — | 30 Sep 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.63%
|
1,969,500
|
$14,574,000 | — | 30 Sep 2016 | |
| Artal Group S.A. |
13F
|
Company |
0.61%
|
1,900,000
|
$14,060,000 | — | 30 Sep 2016 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.59%
|
1,844,529
|
$13,650,000 | — | 30 Sep 2016 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.52%
|
1,638,471
|
$12,125,000 | — | 30 Sep 2016 | |
| CQS Cayman LP |
13F
|
Company |
0.52%
|
1,623,000
|
$12,010,000 | — | 30 Sep 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.51%
|
1,600,116
|
$11,841,000 | — | 30 Sep 2016 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.43%
|
1,354,790
|
$10,025,000 | — | 30 Sep 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.43%
|
1,354,827
|
$10,023,000 | — | 30 Sep 2016 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.41%
|
1,270,437
|
$9,401,000 | — | 30 Sep 2016 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.35%
|
1,104,117
|
$8,170,000 | — | 30 Sep 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
1,069,349
|
$7,913,000 | — | 30 Sep 2016 | |
| S.c.a. Candriam |
13F
|
Individual |
0.32%
|
986,900
|
$7,303,000 | — | 30 Sep 2016 | |
| Invesco Ltd. |
13F
|
Company |
0.31%
|
982,382
|
$7,270,000 | — | 30 Sep 2016 | |
| NORGES BANK |
13F
|
Company |
0.33%
|
1,018,862
|
$7,201,000 | — | 30 Sep 2016 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.29%
|
905,000
|
$6,697,000 | — | 30 Sep 2016 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.24%
|
754,700
|
$5,584,000 | — | 30 Sep 2016 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.23%
|
703,372
|
$5,205,000 | — | 30 Sep 2016 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.22%
|
695,000
|
$5,143,000 | — | 30 Sep 2016 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.21%
|
670,000
|
$4,958,000 | — | 30 Sep 2016 | |
| Asymmetry Capital Management, L.P. |
13F
|
Company |
0.2%
|
618,317
|
$4,576,000 | — | 30 Sep 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
587,202
|
$4,345,000 | — | 30 Sep 2016 | |
| Asset Management One Co., Ltd. |
13F
|
Company |
0.18%
|
565,245
|
$3,996,000 | — | 30 Sep 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.17%
|
527,392
|
$3,903,000 | — | 30 Sep 2016 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
505,081
|
$3,738,000 | — | 30 Sep 2016 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.15%
|
461,446
|
$3,415,000 | — | 30 Sep 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.15%
|
453,851
|
$3,358,000 | — | 30 Sep 2016 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.14%
|
450,076
|
$3,331,000 | — | 30 Sep 2016 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.13%
|
420,836
|
$3,114,000 | — | 30 Sep 2016 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
378,641
|
$2,802,000 | — | 30 Sep 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.12%
|
374,769
|
$2,773,000 | — | 30 Sep 2016 | |
| COLUMBUS CIRCLE INVESTORS |
13F
|
Company |
0.11%
|
330,996
|
$2,449,000 | — | 30 Sep 2016 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.1%
|
301,538
|
$2,231,000 | — | 30 Sep 2016 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
261,310
|
$1,934,000 | — | 30 Sep 2016 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.08%
|
258,000
|
$1,909,000 | — | 30 Sep 2016 |
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2016
As of 31 Dec 2016,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
156,858,667 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, Redmile Group, LLC, JENNISON ASSOCIATES LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, JANUS CAPITAL MANAGEMENT LLC, Palo Alto Investors, LLC, STATE STREET CORP, and Sectoral Asset Management Inc.
This page lists
130
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
134
Q4 2016 holders
130
Holder diff
-4
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 Value $ | Q4 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.